Frankfurt am Main, November 09, 2015 -- Moody's Investors Service, ("Moody's") has today affirmed the A2/(P)A2 and Prime-1 ratings of AstraZeneca PLC and its guaranteed subsidiaries and changed the outlook to negative from stable.

Vollständigen Artikel bei Moodys lesen